All data used in this research were derived from the online resources of the Global Burden of Disease Study 2017 (<http://ghdx.healthdata.org/gbd-results-tool>; <http://ghdx.healthdata.org/gbd-2017>).

Introduction {#sec007}
============

Largely as a result of socioeconomic development, the global population has aged rapidly in the last few decades. The ageing population imposes a growing disease burden on the healthcare systems of the world, especially to prevent and treat certain types of diseases and injuries. According to a United Nations report \[[@pmed.1003138.ref001]\], the number of people aged 65 years and older is expected to rise from 0.7 billion (9%) worldwide in 2019 to 1.5 billion (16%) in 2050. Another recent report suggested population ageing will be associated with a 55% increase in global disability-adjusted life years (DALYs) among people aged 60 years and older between 2004 and 2030 \[[@pmed.1003138.ref002]\], indicating more medical resources will be needed to meet the healthcare needs of the elderly worldwide. Health systems in many nations will require reforms to meet this demand based on the health impact of population ageing.

Previous studies have explored specific aspects of the health impact of population ageing and provided policy-makers and researchers with some valuable information \[[@pmed.1003138.ref003]--[@pmed.1003138.ref008]\]. As an example, Moran et al. projected that cardiovascular events will increase by more than 50% between 2010 and 2030 in China as the result of population ageing and population growth \[[@pmed.1003138.ref008]\]. However, most studies either focused on selected geographical locations (e.g., United States \[[@pmed.1003138.ref009],[@pmed.1003138.ref010]\] or England and Wales \[[@pmed.1003138.ref011],[@pmed.1003138.ref012]\]), making their conclusions not generalizable, or focused on selected diseases (e.g., coronary heart disease \[[@pmed.1003138.ref008],[@pmed.1003138.ref011],[@pmed.1003138.ref013]\] or cancer \[[@pmed.1003138.ref004],[@pmed.1003138.ref014]\]).Some studies did not separate the effects of population ageing (typically approximated as changes in age structure \[[@pmed.1003138.ref003],[@pmed.1003138.ref004]\]) from those of population growth \[[@pmed.1003138.ref008]\]. Without separating these effects, accurate estimation of the net effect of population ageing cannot be assessed, and results can be misleading. In addition, studies that estimated the net effect of population ageing adopted different decomposition methods \[[@pmed.1003138.ref004],[@pmed.1003138.ref015]--[@pmed.1003138.ref017]\]. These traditional methods are sensitive to the decomposition order of the 3 components (population growth, population ageing, and mortality change) as well as to the choice of reference group \[[@pmed.1003138.ref018]\], leading to inconsistent results across studies even using the same data. Finally, some studies relied on questionable assumptions, such as stability of age-specific mortality rates or incidence rates in the future \[[@pmed.1003138.ref006],[@pmed.1003138.ref008]\].

To our knowledge, systematic analyses of the health impact of global population ageing across a long time period are absent in the published literature, restricting international organizations such as the World Health Organization and individual governments from making data-driven modifications of their healthcare systems to address the increasing health needs of the senior population. We recently developed a decomposition method that is not influenced by decomposition order and choice of reference group \[[@pmed.1003138.ref018]\]. We used this method to estimate the impact of population ageing on global deaths; to assess the impact by sex, cause of death, and country; and to assess how changes in mortality rates affected the impact of population ageing from 1990 to 2017 globally and nationally.

Methods {#sec008}
=======

Data source {#sec009}
-----------

All data were derived from online resources of the Global Burden of Disease Study 2017 (GBD 2017) \[[@pmed.1003138.ref019],[@pmed.1003138.ref020]\]. As detailed elsewhere \[[@pmed.1003138.ref015]\], GBD 2017 used 7 types of data sources to estimate numbers of deaths by age, sex, and cause of death for 195 countries and territories. Multiple strategies were adopted to impute missing data and to correct underreporting and misclassification, including (a) reattribution of deaths with garbage codes based on the method established by Ahern et al. \[[@pmed.1003138.ref021]\], (b) disaggregation of causes of death that are condensed into aggregated groups according to the invariant relative risks of death by age group compared to a reference age group \[[@pmed.1003138.ref015]\], and (c) noise reduction of 0 counts using a Bayesian noise reduction algorithm \[[@pmed.1003138.ref015]\]. GBD 2017 also estimated age- and sex-specific population sizes based on data from 1,257 censuses and 761 population registry location-years \[[@pmed.1003138.ref022]\].

The present study retrieved estimated numbers of deaths and population sizes by sex, age group, cause of death, and country from 1990 to 2017 from GBD 2017. Based on income categories defined by the World Bank in 2017 \[[@pmed.1003138.ref023]\], we also classified the 195 countries and territories into high-income, upper-middle-income, lower-middle-income, and low-income. We used the level 3 categorization of causes of death from GBD 2017, which includes 169 causes of death \[[@pmed.1003138.ref015]\]. Populations were partitioned into 20 age groups from under 5 years to 95 years and older, with each age group spanning 5 years.

Decomposition method {#sec010}
--------------------

Several methods have been developed to decompose differences in the total number of deaths into contributions from 3 components: population growth, population ageing, and mortality change \[[@pmed.1003138.ref004],[@pmed.1003138.ref015]--[@pmed.1003138.ref017]\]. Each method has pros and cons, but most are sensitive to the choice of decomposition order and the choice of reference group, yielding inconsistent or even conflicting results from the same data \[[@pmed.1003138.ref018]\]. Recently, we developed a decomposition method that overcomes these limitations by calculating the contributions of the 3 components based on the following formulas \[[@pmed.1003138.ref018]\]: $$M_{p} = {\sum_{i = 1}^{20}{{\left( {N_{2} - N_{1}} \right)s}_{i1}m_{i1}}}$$ $$M_{a} = {\sum_{i = 1}^{20}{N_{1}\left( {s_{i2} - s_{i1}} \right)m_{i1}}}$$ $$M_{m} = {\sum_{i = 1}^{20}{N_{1}s_{i1}\left( {m_{i2} - m_{i1}} \right)}}$$ $$I_{pa} = {\sum_{i = 1}^{20}{\left( {N_{2} - N_{1}} \right)\left( {s_{i2} - s_{i1}} \right)m_{i1}}}$$ $$I_{pm} = {\sum_{i = 1}^{20}{\left( {N_{2} - N_{1}} \right)s_{i1}\left( {m_{i2} - m_{i1}} \right)}}$$ $$I_{am} = {\sum_{i = 1}^{20}{N_{1}\left( {s_{i2} - s_{i1}} \right)\left( {m_{i2} - m_{i1}} \right)}}$$ $$I_{pam} = {\sum_{i = 1}^{20}{\left( {N_{2} - N_{1}} \right)\left( {s_{i2} - s_{i1}} \right)\left( {m_{i2} - m_{i1}} \right)}}$$ where *M*~a~, *M*~p~, and *M*~m~ indicate the main effects of the 3 components population ageing, population growth, and mortality change, respectively; *I*~pa~, *I*~pm~, *I*~am~, and *I*~pam~ denote the 2-way and 3-way interactions of the 3 components; *m*~*ij*~ and *s*~*ij*~ denote the age-specific mortality rate and proportion of population, respectively, for the *i*th age group in the *j*th year (*i* = 1, 2, ..., 20; *j* = 1, 2); and *N*~1~ and *N*~2~ represent the population size for group 1 and group 2, respectively. The change in the number of deaths can then be attributed to population ageing, population growth, and change of age-specific mortality rate as follows: $$A = M_{a} + ½I_{pa} + ½I_{am} + ⅓I_{pam}$$ $$P = M_{p} + ½I_{pa} + ½I_{pm} + ⅓I_{pam}$$ $$M = M_{m} + ½I_{pm} + ½I_{am} + ⅓I_{pam}$$

Details about the method are provided in [S1 Text](#pmed.1003138.s005){ref-type="supplementary-material"}. All data analyses were performed using R 3.6.0, and the package "maps" was used to draw the maps.

Data analysis {#sec011}
-------------

Using the decomposition method described above, we calculated the absolute and relative contributions of the 3 components (population growth, population ageing, and mortality change) to the difference in number of total deaths and subgroup deaths between 1990 and each year from 1991 to 2017 for the global population as well as for each country/territory included in this study. The absolute contribution was the number of attributed deaths, while the relative contribution ("attributed proportion") was estimated as the number of attributed deaths divided by the total number of deaths in 1990 × 100%. A positive contribution indicates an increase in total deaths, while a negative contribution indicates a decrease in total deaths.

We plotted the absolute contributions of the 3 components to the changes in total deaths from 1991 to 2017. The relative contributions of population ageing across the study time period were graphed by sex for the world and for the 4 World Bank income categories. We tabulated the 10 causes of death with the greatest increase in the number of deaths associated with population ageing between 1990 and 2017 by sex, as well as the 10 causes of death with the greatest decrease in number of deaths related to population ageing. We estimated country-specific relative contributions of population ageing from 1990 to 2017 by sex and cause of death.

Last, for countries where population ageing was associated with increases in deaths between 1990 and 2017, we calculated the ratio of the number of deaths attributed to mortality change to that attributed to population ageing (*R*) to assess the comparative contributions of mortality changes (reductions in most countries) versus population ageing to changes in total deaths. *R* \< −1 suggests that the effect of mortality decrease in reducing the total deaths is larger than the effect of population ageing in increasing the total deaths. *R* = −1 indicates that the effects of mortality reduction and of population ageing are equal and thus offset each other, and −1 \< *R* \< 0 suggests the effect of mortality reduction is less than that of population ageing. Finally, *R* \> 0 suggests changes in mortality rates and population ageing were related to increases in deaths between 1990 and 2017. All analyses were stratified by sex because the impact of population ageing differs between males and females \[[@pmed.1003138.ref004],[@pmed.1003138.ref008]\].

We finalized the analysis strategies in June 2019, including exploring patterns in deaths attributed to population ageing, variation in number of attributed deaths, and change in number of attributed deaths across sex, country income category, and cause of death, as well as comparing the effect of mortality change to the effect of population ageing. Data analyses were completed June--August 2019. This research was performed and reported adhering to the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) statement ([S1 GATHER](#pmed.1003138.s001){ref-type="supplementary-material"} Checklist) \[[@pmed.1003138.ref024]\].

Results {#sec012}
=======

Population ageing {#sec013}
-----------------

According to GBD 2017 population estimates, the number of people aged 65 years and older increased by 105% globally from 1990 (327.6 million) to 2017 (673.7 million); the number of global deaths increased from 19.1 million to 32.2 million in the same time period ([Table 1](#pmed.1003138.t001){ref-type="table"}). The proportion of people aged 65 years and older increased from 12.1% (121.5 million) to 17.5% (208.6 million), from 5.6% (119.0 million) to 10.3% (270.5 million), and from 3.9% (75.1 million) to 5.5% (170.6 million) between 1990 and 2017 in high-, upper-middle-, and lower-middle-income countries, respectively, but decreased from 3.2% (10.7 million) to 3.1% (20.8 million) in low-income countries. Accordingly, the proportion of people younger than 30 years was much lower and decreased more in high-, upper-middle-, and lower-middle-income countries (from 44.7% \[447.1 million\] to 35.1% \[4,17.8 million\], 59.5% \[1,256.9 million\] to 41.5% \[1,096.3 million\], and 66.5% \[1,282.4 million\] to 58.3% \[1,819.3 million\], respectively) between 1990 and 2017, compared to that in low-income countries (from 71.9% \[236.8 million\] to 70.6% \[470.6 million\]). The changes in the proportion of people aged 65 years and older for each country/territory are shown in [S1 Table](#pmed.1003138.s002){ref-type="supplementary-material"}.

10.1371/journal.pmed.1003138.t001

###### Number of population (in millions) and deaths (in millions) in 1990 and 2017 globally and by country income category.

![](pmed.1003138.t001){#pmed.1003138.t001g}

  Variable               Value     Global    Country income category                                                                   
  ---------------------- --------- --------- ------------------------- ------- ------- --------- --------- --------- --------- ------- -------
  **Population**                                                                                                                       
  Sex                                                                                                                                  
      Male               Number    2,717.5   3,834.5                   491.8   591.5   1,067.3   1,322.2   983.7     1,576.3   162.5   330.1
                         Percent   50.4%     50.2%                     49.2%   49.7%   50.6%     50.2%     51.0%     50.5%     49.3%   49.5%
      Female             Number    2,677.2   3,806.0                   508.8   598.1   1,044.1   1,312.7   945.6     1,544.5   167.1   336.7
                         Percent   49.6%     49.8%                     50.8%   50.3%   49.4%     49.8%     49.0%     49.5%     50.7%   50.5%
  Age group                                                                                                                            
      \<30 years old     Number    3,237.4   3,815.1                   447.1   417.8   1,256.9   1,096.3   1,282.4   1,819.3   236.8   470.6
                         Percent   60.0%     49.9%                     44.7%   35.1%   59.5%     41.6%     66.5%     58.3%     71.9%   70.6%
      30--64 years old   Number    1,829.8   3,151.7                   431.9   563.1   735.5     1,268.1   571.8     1,130.9   82.1    175.4
                         Percent   33.9%     41.3%                     43.2%   47.3%   34.8%     48.1%     29.6%     36.2%     24.9%   26.3%
      ≥65 years old      Number    327.6     673.7                     121.5   208.6   119.0     270.5     75.1      170.6     10.7    20.8
  Percent                6.1%      8.8%      12.1%                     17.5%   5.6%    10.3%     3.9%      5.5%      3.2%      3.1%    
  **Number of deaths**                                                                                                                 
  Sex                                                                                                                                  
      Male               Number    24.9      30.4                      4.5     5.3     8.0       10.7      9.8       11.6      2.6     2.6
                         Percent   53.6%     54.3%                     51.9%   50.9%   54.4%     56.4%     53.7%     54.2%     53.7%   54.1%
      Female             Number    21.6      25.6                      4.1     5.2     6.7       8.3       8.5       9.8       2.2     2.2
                         Percent   46.4%     45.7%                     48.1%   49.1%   45.6%     43.6%     46.3%     45.8%     46.3%   45.9%
  Age group                                                                                                                            
      \<30 years old     Number    15.6      8.2                       0.4     0.2     3.5       1.1       8.6       4.6       3.0     2.2
                         Percent   33.5%     14.6%                     4.8%    1.9%    24.0%     5.8%      47.1%     21.6%     62.2%   46.1%
      30--64 years old   Number    11.8      15.5                      1.9     1.9     4.3       5.3       4.6       7.0       1.0     1.3
                         Percent   25.4%     27.8%                     22.4%   17.7%   29.2%     28.0%     24.9%     32.5%     20.8%   27.3%
      ≥65 years old      Number    19.1      32.2                      6.3     8.4     6.9       12.5      5.1       9.8       0.8     1.3
  Percent                41.1%     57.6%     72.8%                     80.4%   46.8%   66.1%     27.9%     45.8%     17.0%     26.5%   

Change in global deaths attributed to population ageing {#sec014}
-------------------------------------------------------

Using 1990 as the baseline, the increase in the number of global deaths attributed to population ageing grew gradually from 1991 to 2017 and reached 12 million in 2017 ([Fig 1](#pmed.1003138.g001){ref-type="fig"}). Between 1990 and 2017, population growth was associated with an increase of 12 million deaths, while mortality change (i.e., reductions in most age-specific mortality rates) was associated with a decrease of 21 million deaths.

![Global death changes associated with population ageing, population growth, and mortality change from 1990 to 2017.\
The decomposition was conducted using the number of deaths in 1990 as the reference for each year.](pmed.1003138.g001){#pmed.1003138.g001}

The proportion of deaths attributed to population change rose steadily between 1991 and 2017 for the world overall and for high-, upper-middle-, and lower-middle-income countries ([Fig 2](#pmed.1003138.g002){ref-type="fig"}). The attributed proportion increased more sharply in high-, upper-middle-, and lower-middle-income countries compared to low-income countries. These patterns were similar for both males and females. The attributed proportion among males was 27.9% (7.0 million) for the world and was 51.2% (2.3 million), 56.2% (4.5 million), 12.2% (1.2 million), and −7.4% (−0.2 million) for high-, upper-middle-, lower-middle-, and low-income countries between 1990 and 2017, respectively ([Fig 2A](#pmed.1003138.g002){ref-type="fig"}). The corresponding numbers globally and by country income category for females were 26.0% (5.6 million), 50.6% (2.1 million), 55.6% (3.7 million), 14.0% (1.2 million), and −3.2% (−72,000), respectively ([Fig 2B](#pmed.1003138.g002){ref-type="fig"}). The negative attributed proportion in low-income countries results from decreases in the proportion of people aged 65 years and older (from 3.2% to 3.1%) and the fact that older adults have much higher overall mortality rates than young people.

![Proportion of deaths associated with population ageing globally and by country income category, 1990--2017.\
(A) Male; (B) female. Decomposition analysis was conducted using the number of deaths in 1990 as the reference. The attributed proportion of deaths was calculated as the number of deaths attributed to population ageing divided by total deaths in 1990 × 100%.](pmed.1003138.g002){#pmed.1003138.g002}

The impact of population ageing significantly differed across causes of death ([Table 2](#pmed.1003138.t002){ref-type="table"}). Among males, across the 169 causes of death, population ageing was most significantly associated with increases in deaths from ischemic heart disease (1.74 million), stroke (1.13 million), chronic obstructive pulmonary disease (0.77 million), and tracheal, bronchial, and lung cancer (0.38 million) between 1990 and 2017. As an accompanying effect of population ageing, the percentage of children in the population decreased gradually, with associated reductions of deaths from neonatal disorders (0.39 million) and congenital birth defects (0.10 million) between 1990 and 2017. The cause-specific decomposition results for females were roughly similar to those for males, although the magnitudes of the contributions were somewhat lower and the ranks slightly differ.

10.1371/journal.pmed.1003138.t002

###### Top 10 causes of death with the highest increase and decrease in the number (in thousands) and proportion associated with population ageing between 1990 and 2017.
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  Rank   Male                                            Female                                                         
  ------ ----------------------------------------------- -------------- ----------------------------------------------- --------------
  1      Ischemic heart disease                          1,735 (7.0%)   Ischemic heart disease                          1,470 (6.8%)
  2      Stroke                                          1,126 (4.5%)   Stroke                                          1,067 (4.9%)
  3      Chronic obstructive pulmonary disease           771 (3.1%)     Alzheimer disease and other types of dementia   621 (2.9%)
  4      Tracheal, bronchial, and lung cancer            379 (1.5%)     Chronic obstructive pulmonary disease           516 (2.4%)
  5      Alzheimer disease and other types of dementia   356 (1.4%)     Hypertensive heart disease                      172 (0.8%)
  6      Tuberculosis                                    227 (0.9%)     Diabetes mellitus                               170 (0.8%)
  7      Cirrhosis and other chronic liver diseases      214 (0.9%)     Breast cancer                                   146 (0.7%)
  8      Stomach cancer                                  199 (0.8%)     Chronic kidney disease                          137 (0.6%)
  9      Diabetes mellitus                               170 (0.7%)     Tracheal, bronchial, and lung cancer            135 (0.6%)
  10     Chronic kidney disease                          169 (0.7%)     Colon and rectum cancer                         120 (0.6%)
  160    Typhoid and paratyphoid                         −15 (−0.1%)    Typhoid and paratyphoid                         −14 (−0.1%)
  161    Whooping cough                                  −17 (−0.1%)    Drowning                                        −14 (−0.1%)
  162    Drowning                                        −20 (−0.1%)    Tetanus                                         −14 (−0.1%)
  163    Sexually transmitted infections excluding HIV   −21 (−0.1%)    Whooping cough                                  −21 (−0.1%)
  164    Protein-energy malnutrition                     −22 (−0.1%)    Meningitis                                      −26 (−0.1%)
  165    Meningitis                                      −28 (−0.1%)    Protein-energy malnutrition                     −27 (−0.1%)
  166    Malaria                                         −53 (−0.2%)    Malaria                                         −51 (−0.2%)
  167    Measles                                         −55 (−0.2%)    Measles                                         −57 (−0.3%)
  168    Congenital birth defects                        −100 (−0.4%)   Congenital birth defects                        −91 (−0.4%)
  169    Neonatal disorders                              −390 (−1.6%)   Neonatal disorders                              −314 (−1.5%)

The attributed proportion for males was calculated as the number of deaths attributed to population ageing for each cause of death/24.9 million (total male deaths in 1990) × 100%. The attributed proportion for females was calculated as the number of deaths attributed to population ageing for each cause of death/21.6 million (total female deaths in 1990) × 100%.

Change in country-specific deaths attributed to population ageing {#sec015}
-----------------------------------------------------------------

Population ageing was associated with increases in deaths for males in 152 countries and territories between 1990 and 2017, but decreases in deaths for males in 43 countries and territories, primarily in Africa ([Fig 3A](#pmed.1003138.g003){ref-type="fig"}). The latter results were the consequence of the decreased proportion of people aged 65 years and older and the fact that older age groups have higher all-cause mortality rates than younger age groups. The proportion of changes in male deaths associated with population ageing between 1990 and 2017 ranged from −44% in Afghanistan to 117% in Japan.

![Proportion of deaths associated with population ageing between 1990 and 2017 in 195 countries and territories.\
(A) Male; (B) female. The attributed proportion was calculated as the change in total deaths attributed to population ageing between 1990 and 2017 divided by total deaths in 1990 × 100%. Countries and territories with negative attributed proportions were treated as a single category. Countries with positive attributed proportions were classified into 5 categories according to quintiles of positive attributed proportions. The maps were drawn using the R package "maps," which was based on the data from the Natural Earth project.](pmed.1003138.g003){#pmed.1003138.g003}

The geographic variation in attributed proportion for females differed moderately from that for males ([Fig 3B](#pmed.1003138.g003){ref-type="fig"}). Among females, population ageing was associated with increases in deaths in 159 countries and territories, and decreases in deaths in 36 countries and territories, between 1990 and 2017. Similar to the pattern for males, Japan had the highest attributed proportion of female deaths (154%) and Afghanistan had the lowest (−30%).

[Table 3](#pmed.1003138.t003){ref-type="table"} shows that ischemic heart disease and stroke were the 2 causes of death that were most adversely affected by population ageing between 1990 and 2017 for both males and females. Fourteen countries had ≥20% net increase in ischemic heart disease deaths attributed to population ageing among males, and 23 countries among females. Most were high-income countries. Two countries/territories had attributed proportions greater than 20% for stroke-related deaths among males (Albania, 22%; South Korea, 22%), and 7 among females (South Korea, 29%; Japan, 26%; Macedonia, 24%; Portugal, 22%; Bosnia and Herzegovina, 22%; Montenegro, 22%; and Taiwan of China, 21%) ([S2 Table](#pmed.1003138.s003){ref-type="supplementary-material"}).

10.1371/journal.pmed.1003138.t003

###### Number of countries and territories with different increases in cause-specific proportions of deaths associated with population ageing between 1990 and 2017.
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  Sex and cause of death                          Increase in attributed proportion of deaths (number of countries/territories)                  
  ----------------------------------------------- ------------------------------------------------------------------------------- ---- ---- ---- ----
  **Male**                                                                                                                                       
  Ischemic heart disease                          29                                                                              43   38   29   14
  Stroke                                          79                                                                              51   10   4    2
  Chronic obstructive pulmonary disease           110                                                                             8    1    0    0
  Alzheimer disease and other types of dementia   101                                                                             4    1    0    0
  Tracheal, bronchial, and lung cancer            87                                                                              13   0    0    0
  Chronic kidney disease                          75                                                                              2    0    0    0
  Cirrhosis and other chronic liver diseases      76                                                                              1    0    0    0
  Diabetes mellitus                               68                                                                              8    0    0    0
  Lower respiratory infections                    69                                                                              6    1    0    0
  Prostate cancer                                 69                                                                              3    0    0    0
  Colon and rectum cancer                         59                                                                              0    0    0    0
  Stomach cancer                                  55                                                                              2    0    0    0
  Hypertensive heart disease                      43                                                                              0    0    0    0
  Road injuries                                   26                                                                              1    0    0    0
  Tuberculosis                                    27                                                                              0    0    0    0
  **Female**                                                                                                                                     
  Ischemic heart disease                          40                                                                              40   29   25   23
  Stroke                                          61                                                                              57   23   8    7
  Alzheimer disease and other types of dementia   76                                                                              41   10   1    2
  Chronic obstructive pulmonary disease           92                                                                              5    1    0    1
  Diabetes mellitus                               82                                                                              13   3    0    0
  Breast cancer                                   87                                                                              2    0    0    0
  Chronic kidney disease                          77                                                                              2    1    0    0
  Hypertensive heart disease                      79                                                                              1    0    0    0
  Lower respiratory infections                    67                                                                              6    3    0    0
  Colon and rectum cancer                         57                                                                              0    0    0    0
  Cirrhosis and other chronic liver diseases      45                                                                              0    0    0    0
  Tracheal, bronchial, and lung cancer            38                                                                              2    0    0    0
  Stomach cancer                                  38                                                                              0    0    0    0
  Cervical cancer                                 37                                                                              0    0    0    0
  Other cardiovascular and circulatory diseases   23                                                                              0    0    0    0
  Atrial fibrillation and flutter                 22                                                                              0    0    0    0
  Cardiomyopathy and myocarditis                  19                                                                              1    0    0    0

The attributed proportion was calculated as the number of deaths attributed to population ageing for each cause of death between 1990 and 2017 divided by total deaths in 1990 × 100% for males and females, respectively. Diseases with an attributed proportion of 0% to \<1% and diseases with an attributed proportion of ≥1% in less than 20 countries and territories are omitted.

With a few exceptions, the proportion of death increase associated with population ageing between 1990 and 2017 was less than 10% for most diseases in both sexes ([Table 3](#pmed.1003138.t003){ref-type="table"}). For males, the attributed proportion was 13% for chronic obstructive pulmonary disease in China, 10% for Alzheimer disease and other types of dementia in Japan, and 12% for lower respiratory infections in Japan. The attributed proportion was greater than 10% for Alzheimer disease and other types of dementia in 13 countries and territories for females. The attributed proportion for chronic obstructive pulmonary disease was 20% in Korea and 14% in China for females. The attributed proportion for diabetes mellitus exceeded 10% in Fiji (14%), Northern Mariana Islands (11%), and Trinidad and Tobago (11%) for females. For chronic kidney disease, only the Northern Mariana Islands (11%) had an attributed proportion greater than 10% for females. Three countries had an attributed proportion exceeding 10% for lower respiratory infections for females: Japan (12%), Singapore (11%), and Andorra (11%) ([S2 Table](#pmed.1003138.s003){ref-type="supplementary-material"}).

Comparative contributions of mortality reduction versus population ageing {#sec016}
-------------------------------------------------------------------------

Globally, the decrease in deaths attributed to mortality reduction far exceeded the increase in deaths related to population ageing between 1990 and 2017 (−21 million versus 12 million) ([Fig 1](#pmed.1003138.g001){ref-type="fig"}). In fact, the ratio (*R*) of the decrease in deaths (a negative change) attributed to mortality reduction to the increase in deaths (a positive change) related to population ageing between 1990 and 2017 was −1.6 for males and −1.8 for females. The ratio differed greatly across sex and country income categories; it was −1.0, −0.8, and −3.8 for males in high-, upper-middle-, and lower-middle-income countries, respectively, and −0.9, −1.0, and −3.7 for females in high-, upper-middle-, and lower-middle-income countries, respectively. Because the proportion of people aged 65 years and older decreased in most low-income countries, we did not analyze the comparative contributions of mortality reduction versus population ageing for this category.

Of the 152 countries that experienced an increase in male deaths related to population ageing between 1990 and 2017, 77 countries and territories (51%) had *R* ≤ −1, 66 (43%) had −1 \< *R* ≤ 0, and 9 (6%) had *R* \> 0 (Guam, Jamaica, Lesotho, North Korea, Swaziland, Syria, Ukraine, US Virgin Islands, and Uzbekistan) ([Fig 4A](#pmed.1003138.g004){ref-type="fig"}). The lowest ratio was in Eritrea (−161), and the highest was in Lesotho (16).

![Ratio between total deaths attributed to change in mortality rate and total deaths associated with population ageing between 1990 and 2017.\
(A) Male; (B) female. The ratio was calculated as the change in total deaths attributed to change in mortality rate divided by that associated with population ageing. Blue signifies countries and territories for which the decrease in total deaths attributed to changes in mortality was more than the increase attributed to population ageing between 1990 and 2017. Red signifies countries and territories for which the decrease in total deaths attributed to changes in mortality was less than the increase associated with population ageing between 1990 and 2017. White signifies countries and territories not experiencing an increase in deaths associated with population ageing between 1990 and 2017. The maps were drawn using the R package "maps," which was based on the data from the Natural Earth project.](pmed.1003138.g004){#pmed.1003138.g004}

Among females, 159 (82%) countries and territories experienced an increase in deaths attributed to population ageing between 1990 and 2017 ([Fig 4B](#pmed.1003138.g004){ref-type="fig"}). Of these, 76 (48%) had *R* ≤ −1, 78 (49%) had −1 \< *R* ≤ 0, and 5 (3%) had *R* \> 0 (American Samoa, Guam, Lesotho, Serbia, and Swaziland). The lowest ratio was in Zambia (−119), and the highest was in Lesotho (4). Detailed country-specific ratios appear in [S3 Table](#pmed.1003138.s004){ref-type="supplementary-material"}.

Discussion {#sec017}
==========

In this study, we reported on global death changes from 1990 to 2017 attributed to population ageing for 169 causes of death both globally and by country/territory using a decomposition method. We have 4 key findings. First, population ageing was associated with an increase of 12 million deaths worldwide between 1990 and 2017. The death increases occurred primarily in high-, upper-middle-, and lower-middle-income countries; in fact, many low-income countries experienced decreases in deaths attributed to population ageing. Second, between 1990 and 2017, most of the increases in deaths related to population ageing were from ischemic heart disease (1.74 million for males and 1.47 million for females) and stroke (1.13 million for males and 1.07 million for females). Third, the impact of population ageing greatly varied across countries and territories, causing increases in deaths in most countries but decreases in deaths in some countries. The country-specific impacts also differed by cause of death. Last, the increase in deaths related to population ageing between 1990 and 2017 was outweighed by the decrease in deaths attributed to mortality reduction both globally (−21 million versus 12 million) and in about half of the countries and territories that experienced an increase in deaths attributed to population ageing.

This study offers a comprehensive set of estimates concerning the health impact of population ageing. Previous publications reported that population ageing was associated with increases in deaths from ischemic heart disease, chronic kidney disease, and cardiovascular deaths globally \[[@pmed.1003138.ref017],[@pmed.1003138.ref025]\] and with deaths from coronary heart disease and musculoskeletal disorders in selected countries \[[@pmed.1003138.ref011],[@pmed.1003138.ref026]\]. Our analyses are distinct in 2 primary ways: (a) examining global deaths attributed to population ageing for 169 causes of death across 195 countries and territories and (b) using a decomposition method that is independent of the choice of decomposition order and reference group, to generate more robust estimates. Consistent with previous findings \[[@pmed.1003138.ref011],[@pmed.1003138.ref017],[@pmed.1003138.ref025],[@pmed.1003138.ref026]\], this study demonstrates heterogeneous health impacts of population ageing across countries. We report increased death burden in many countries but reduced death burden in some countries (typically low-income countries/territories). The contrasting results are likely due to different changes in the age structure of populations across countries/territories (see Tables [1](#pmed.1003138.t001){ref-type="table"} and [S1](#pmed.1003138.s002){ref-type="supplementary-material"}), as well as great variations in mortality rates across age groups.

Among our notable findings is the fact that population ageing/de-ageing was associated with decreases in deaths from some diseases (for example, ischemic heart disease) in some low-income countries, such as Afghanistan, Liberia, and Guinea, despite being associated with increases in deaths from these diseases globally \[[@pmed.1003138.ref017]\]. Such results likely reflect differences in demographic changes across nations. The proportion of people aged 65 years and older increased from 12.1% to 17.5% in high-income countries but decreased from 3.2% to 3.1% in low-income countries between 1990 and 2017 \[[@pmed.1003138.ref020]\]. Thus, population ageing/de-ageing was associated with varying health impacts across countries and territories. International organizations and national governments should weigh these variations when developing and implementing action plans to improve health, or tailoring prevention programs to face the potential health impact from population ageing in particular regions and countries.

A key strength of this study was our use of a decomposition method that functions independently of the choice of decomposition order and reference group to comprehensively estimate the health impact of population ageing from 1990 to 2017 for the whole world as well as for 195 individual countries/territories. We considered both all-cause mortality and cause-specific mortality for 169 causes of death. Our decomposition results can be compared across countries/territories and across causes of death, regardless of decomposition order of the factors and the choice of reference group. In addition, we evaluated the extent to which changes in mortality rate alleviated or exceeded the increases in deaths related to population ageing, exploring the importance of prevention efforts to reduce age-specific mortality.

This study has several limitations. First, our results depend on the quality of the estimates for the numbers of deaths and population sizes from GBD 2017. They are therefore affected by factors that impact the accuracy of the GBD 2017 estimates, including lack of high-quality mortality and migration data for some countries and lack of widely validated estimation methods \[[@pmed.1003138.ref015],[@pmed.1003138.ref022]\]. Second, we cannot provide 95% confidence intervals for our estimates because we are unable to access the full posterior samples of cause-specific mortality rates stratified by age, sex, location, and year from the GBD 2017 study \[[@pmed.1003138.ref005],[@pmed.1003138.ref015],[@pmed.1003138.ref022]\]. Third, population ageing can be caused both by decreasing fertility rates and by increasing life expectancy \[[@pmed.1003138.ref002],[@pmed.1003138.ref027]\]. The method used in this study does not explore the 2 mechanisms of population ageing. Fourth, the method used in this study only considers 3 factors, and thus ignores any heterogeneity underlying other factors related to changes in total mortality. For example, temporal changes in age structure or mortality rates may vary by sex or income level. We conducted analyses specific to each subpopulation defined by sex, country income level, and cause of death and thus partially accounted for such heterogeneity. These limitations could be overcome through methodological innovations and improving data quality in future research.

This study offers valuable data and insights to guide health policy-making and reform of health systems, especially in countries experiencing rapid population ageing such as South Korea, Japan, and China. Our results demonstrate the success and promise of disease prevention and health promotion efforts. Encouragingly, the increase in deaths related to population ageing was outweighed by the decrease in deaths attributed to mortality rate reductions between 1990 and 2017. This was true both globally and in about half the countries and territories studied. The challenges brought about to society through population ageing can therefore be substantially alleviated through disease prevention and health promotion. Despite an ageing global population, mortality rates worldwide are decreasing \[[@pmed.1003138.ref008]\]. To maintain these successes, health resources should be allocated to further reduce mortality rates in countries/territories where the effect of population ageing much outweighed that of mortality reduction, as illuminated by our findings. As lower income countries experience economic, infrastructure, and public health improvements, they may face challenges from population ageing similar to the challenges higher income nations are now confronting. They should benefit from the lessons learned in higher income countries, and should invest in proven interventions to promote healthy ageing \[[@pmed.1003138.ref028]--[@pmed.1003138.ref030]\]. As an example, scholars have highlighted the successful efforts of Canada in promoting active, healthy ageing through strategies such as collaborating with various stakeholders to advocate physical activity, and have argued that these efforts could readily be adapted and disseminated in sub-Saharan African countries \[[@pmed.1003138.ref028]\]. Our results help identify countries with successful experiences, especially those with reduced age-specific mortality outweighing population ageing, in shaping the long-term pattern of death burden.

Conclusions {#sec018}
===========

This study identified a global pattern of increased disease-related deaths attributed to population ageing from 1990 to 2017. Because of heterogeneity in age structure and age-specific mortality rates, the impact of population ageing on deaths varied by sex, country income level, country, and cause of death. The increase in deaths related to population ageing was largely offset by mortality reductions both globally and in about half of individual countries and territories. To respond to the increase in deaths related to population ageing for some causes of death, policy-makers should invest more in preventive medicine, ageing-related health research, and implementation of proven cost-effective interventions against chronic diseases and injuries.
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Dear Dr. Hu,

Thank you very much for submitting your manuscript \"Impact of population ageing on global deaths, 1990-2017\" (PMEDICINE-D-19-03747) for consideration at PLOS Medicine.

Your paper was evaluated by a senior editor and discussed among the editors here. It was also discussed with an academic editor with relevant expertise, and sent to independent reviewers, including a statistical reviewer. The reviews are appended at the bottom of this email and any accompanying reviewer attachments can be seen via the link below:

\[LINK\]

In light of these reviews, I am afraid that we will not be able to accept the manuscript for publication in the journal in its current form, but we would like to consider a revised version that addresses the reviewers\' and editors\' comments. Obviously we cannot make any decision about publication until we have seen the revised manuscript and your response, and we plan to seek re-review by one or more of the reviewers.

In revising the manuscript for further consideration, your revisions should address the specific points made by each reviewer and the editors. Please also check the guidelines for revised papers at <http://journals.plos.org/plosmedicine/s/revising-your-manuscript> for any that apply to your paper. In your rebuttal letter you should indicate your response to the reviewers\' and editors\' comments, the changes you have made in the manuscript, and include either an excerpt of the revised text or the location (eg: page and line number) where each change can be found. Please submit a clean version of the paper as the main article file; a version with changes marked should be uploaded as a marked up manuscript.

In addition, we request that you upload any figures associated with your paper as individual TIF or EPS files with 300dpi resolution at resubmission; please read our figure guidelines for more information on our requirements: <http://journals.plos.org/plosmedicine/s/figures>. While revising your submission, please upload your figure files to the PACE digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <PLOSMedicine@plos.org>.

We expect to receive your revised manuscript by Feb 12 2020 11:59PM. Please email us (<plosmedicine@plos.org>) if you have any questions or concerns.

\*\*\*Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.\*\*\*

We ask every co-author listed on the manuscript to fill in a contributing author statement, making sure to declare all competing interests. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. If new competing interests are declared later in the revision process, this may also hold up the submission. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT. You can see our competing interests policy here: <http://journals.plos.org/plosmedicine/s/competing-interests>.

Please use the following link to submit the revised manuscript:

<https://www.editorialmanager.com/pmedicine/>

Your article can be found in the \"Submissions Needing Revision\" folder.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see <http://journals.plos.org/plosmedicine/s/submission-guidelines#loc-methods>.

Please ensure that the paper adheres to the PLOS Data Availability Policy (see <http://journals.plos.org/plosmedicine/s/data-availability>), which requires that all data underlying the study\'s findings be provided in a repository or as Supporting Information. For data residing with a third party, authors are required to provide instructions with contact information for obtaining the data. PLOS journals do not allow statements supported by \"data not shown\" or \"unpublished results.\" For such statements, authors must provide supporting data or cite public sources that include it.

We look forward to receiving your revised manuscript.
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Louise Gaynor-Brook, MBBS PhD

Associate Editor

on behalf of:

Thomas McBride, PhD

Senior Editor
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Requests from the editors:

General comments: The flow of the main text is, at times, difficult to follow. It would be appreciated if your manuscript could be proofread thoroughly by someone with full professional proficiency in English prior to resubmission.

Please remove indents from the beginning of paragraphs.

Please revise your title according to PLOS Medicine\'s style, placing the study design in the subtitle (ie, after a colon). We suggest \"Population ageing and mortality during 1990-2017: a global cross-sectional analysis\" or similar.

Abstract Background: Please expand upon the context of why the study is important. The final sentence should clearly state the study question.

Please combine the Methods and Findings components of your Abstract under 'Methods and Findings'

Please include the study design, number of individuals included in the GBD 2017 dataset, and brief demographic details e.g. age, sex, distribution of data according to income categories, etc.

Please expand upon the results relating to variation due to economic development levels and geographic regions

Line 38 - Please report your results for increases and decreases in deaths in separate sentences.

Please include the important dependent variables that are adjusted for in the analyses.

In the last sentence of the Abstract Methods and Findings section, please describe the main limitation(s) of the study\'s methodology.

Please begin your Abstract Conclusions with "\"In this study, we observed \...\" or similar. Please address the study implications substantiated by the results, emphasizing what is new without overstating your conclusions.

At this stage, we ask that you include a short, non-technical Author Summary of your research to make findings accessible to a wide audience that includes both scientists and non-scientists. The Author Summary should immediately follow the Abstract in your revised manuscript. This text is subject to editorial change and should use non-identical language distinct from the scientific abstract. Please see our author guidelines for more information: <https://journals.plos.org/plosmedicine/s/revising-your-manuscript#loc-author-summary>

Introduction

Please address past research and explain the need for and potential importance of your study. Indicate whether your study is novel and how you determined that. If there has been a systematic review of the evidence related to your study (or you have conducted one), please refer to and reference that review and indicate whether it supports the need for your study.

Line 65 - please expand upon the importance of an increase in global disability adjusted life years (DALYs)

Line 88 - please revise 'currently lacking' and 'novel' to avoid assertions of primacy

Methods

Please report your data according to GATHER and enclose a completed GATHER checklist as a supplementary document. See <http://gather-statement.org/> In the checklist please include sufficient text excerpted from the manuscript to explain how you accomplished all applicable items. When completing the checklist, please use section titles and paragraph numbers, rather than page numbers.

Did your study have a prospective protocol or analysis plan? Please state this (either way) early in the Methods section. If a prospective analysis plan was used in designing the study, please include the relevant prospectively written document with your revised manuscript as a Supporting Information file to be published alongside your study, and cite it in the Methods section. If no such document exists, please make sure that the Methods section transparently describes when analyses were planned, and when/why any data-driven changes to analyses took place.

Results

Please include as Table 1 a summary of the number of individuals included in the GBD 2017 dataset, and baseline demographic data e.g. age, sex, distribution of data according to income categories, etc.

Line 203 - please revise to 'bronchial'

Line 219 - please expand upon how changes in male deaths "can be explained by increases in the percentage of younger population"

Line 242 - please revise sentence beginning 'Fourteen (23) countries' to better distinguish between results presented for males and females

Lines 253, 254 - please revise to 'other types of dementia'

Lines 255 - 261: please clarify which sex these results apply to

Figure 3 - Please explain why range of 'negative proportions' (shown in blue) does not extend to zero, and why range of first quintile of the positive proportions begins at 0.7% / 0.8% (and not 0.1)

Figure 4 - please revise title to "Ratios between total deaths attributed to mortality change and deaths attributed to population ageing..."

Please present numerators and denominators for percentages in the Tables.

Table 1 - please revise to 'bronchial'

Table 2 - please revise to 'other types of dementia' ; 'bronchial' ; and 'pulmonary'

Table S2 - please revise to 'other types of dementia'

Discussion

Please remove subheadings from within your Discussion.

Please begin your Discussion with \"In this study" or similar

Please present and organize the Discussion as follows: a short, clear summary of the article\'s findings; what the study adds to existing research and where and why the results may differ from previous research; strengths and limitations of the study; implications and next steps for research, clinical practice, and/or public policy; one-paragraph conclusion.

Line 315 - please revise to 'have caused'

Line 352 - please revise 'high-risk age groups differ across diseases'

Comments from the reviewers:

Reviewer \#1: I mostly confine my remarks to statistical aspects of this paper.

However, as someone who is new to this idea of disagregating these effects, I was a little unclear as to the purpose of the whole exercise. I guess other people already know this, but, since the audience for PLoS will surely include other people like me, it would be good to give a bit more about this in the introduction. I can certainly see why we would want to know, e.g., projections of disease rates and counts in various countries. But I\'m not so clear as to the need for knowing what proportion of the number of deaths is due to aging vs. other causes.

Now, to statistics. These were generally fine. I would like to have a bit more detail in the appendix about the derivation of the formulas. I spent a good bit of time figuring out what was being done and I think it is correct, but the authors could help by spelling out how the various formulas were derived and why they are the way they are.

Line 45-47: I\'m not sure how this follows from the results. I don\'t disagree with the conclusion, but couldn\'t we have concluded this a priori? What possible results would make this conclusion incorrect?

Line 101-102 Some detail of what was done would be good.

Line 120-124: It won\'t really affect anything, but I think the subscripts and formula labels could be better chosen, just to make it easier to follow. There are three factors: Aging, population growth and mortality change. Why not use A, P and M for these, both instead of A, B and C and instead of S, P and M (in the subscripts)?

Fig 1 Stacked bar charts (which is really what this is) aren\'t a great method. See the work of William S. Cleveland. I would use a line graph with year on the x axis, deaths on the y axis and three or four lines (one for each cause and maybe one for total)

Fig 2: First, the y axis can\'t be proportion of deaths - proportions have to add to 1.00 (or, percentages to 100). I\'m not sure what is being graphed here. Is it number of deaths? Second, I\'d put the labels for the lines next to the lines on the right axis for easier reading.

Peter Flom

Reviewer \#2: This work tries to provide a better understanding of the drivers causing (old age) mortality (line 22-23). Conditional on the choice of their models, there is no reason to dispute the data presented. Questions arise however on the framing of work, the underlying assumptions, and the interpretation of the data.

Framing

This work is positioned in a reasoning that \'ageing is a global public health challenge\' (line 21-22). The direct connect between population ageing and public health challenge however, is a postulation, not a fact. The idea that aging is a (negative) \'challenge\' is adhered to by many, but the question is whether it is correct, and or helpful. The key is that a decrease in the force of mortality is a good thing: it is getting better for individuals. It indicates societal progress and achievements, and allows for longer investments into work, society, others. Rephrased otherwise, population ageing can equally be framed as something positive, e.g. the \'silver economy\'. A negative preconception could well be considered a form of ageism.

Assumptions

Not separating the average age of the population and age specific force of mortality can make up every outcome one can think of. It is the explanation why different methods come up with inconsistent results (line 112-117). It is for these reasons that the authors take an absolute stance, \'attributing differences or changes in total deaths to the changes of various components, or factors, such as population size, age structure and mortality rates\' (line 117 onwards). The methodology followed is correct when the absolute number of deaths is the primary endpoint to be considered, e.g. Figure 1. However, it is questionable whether the decomposition method provides \'the robust model\' that is claimed to unravel the drivers of mortality. It can easily be deduced from the figure that the change in total deaths is the net result of population size, force of mortality and age structure, phenomena that are interrelated, but very different between countries depending on what happened over successive generations, calendar time and lifespan. The model allows for including these various interactions, but the consequence is that outcomes of the model are only weighted averages, and different for the whole world, regions, and each country separately. When very strict, this underlying heterogeneity between countries and regions would prohibit statistical pooling...

A similar reasoning can be set up when classifying a nation as an \"ageing country\", even when it is according to the United Nations standard (proportion of people ≥ 65 years old exceeds 7%). Given the huge differences in age specific mortality, morbidity, functionality (e.g. pension age varies between 55 to none) 7% can be appreciated as low, preferred, or high. Moreover, the use of \'ageing countries\' is ambivalent as there may be different underlying processes going on. In extreme, one could argue that some nations that have successfully dealt with early mortality at young age are now finally ageing, which is a positive thing. This is not a semantic discussion, e.g. a careful exploration and presentation of these separate phenomena unmasks the double burden of disease, and explains why these nations can only prosper economically when their populations are ageing.

Interpretation

It is very difficult to infer \'global trend in disease-related deaths attributed to population ageing from 1990 to 2017\' (line 399). The reason is that the underlying demographic dynamics are so different:

\- First, in some countries it could be that: As the number of new-borns decreases, population ageing accelerates as a global public health challenge. The interpretation being that it is the decrease in fertility that is the underlying problem and should be addressed, which reasoning, correct or wrong, is now being followed in several countries of the world;

\- Second, in other countries \'We face as a global public health challenge, as the number of deaths increases because the of baby boom.\' This could well be a true phenomenon but the interpretation is not negative. See that some argue for active family planning to elicit a baby boom, thus wanted. Moreover, at the same time force of mortality could well be going down, thus it is not a public health problem but a late effect of an earlier societal behaviour;

\- Third, for specific countries;\' Life expectancy increases, population ageing accelerates, indicating that a global public health challenge is successfully dealt with.\' For example, life expectancy in Russia dropped because there was a massive alcohol problem. Now this is partially dealt with, the population is ageing again, which is positive.

In conclusion, disaggregation of the impact of ageing on death is a research priority and can best be dealt with when population size, age structure and mortality rates are dealt with in all countries/regions separately, not by pooling what cannot be pooled.

Reviewer \#3: I really enjoyed reading \'Impact of population ageing on global deaths, 1990-2017\' manuscript.

The article aimed to provide a novel robust method to evaluate the global impact of population ageing across a lengthy time period, which it has done successfully in my opinion.

The method showed in the manuscript is simple and robust as the authors claimed. The supplementary method is easy follow and it is sufficient for other researchers to reproduce. It\'d be nice if the authors could expand the supplementary method to a tutorial with an actual example.

The manuscript is well organised and written clearly enough to be accessible to non-specialists. However, as a non native speakers I did not check any grammars.

More explanation of the method would help make the manuscript more complete without readers have to go to the supplementary. Word limits could be an issue but I think authors could shorten the discussion without losing anything important.

Reviewer \#4: Population ageing is obviously associated with increased rates of mortality. In this paper, the authors use data from the Global Burden of Disease to estimate the magnitude of this over the period 1990-2017. To do this, the authors use a novel statistical approach they recently developed that can decompose death differences between populations based on population size, age structure of the population, and age-specific mortality rate. The authors found wide differences across income levels, countries and causes of deaths.

Overall, I thought the paper was interesting and addressed an important topic. I have a few comments that I hope might improve the paper:

1\. The authors could potentially report estimates for the increase in yearly deaths attributable to each year increase in a population\'s average age (controlling for income, country and other factors). Similar estimates could be given for increases in average income and changes in sex ratios. Such figures may be of interest to researchers in ageing and population planning.

2\. The authors currently give breakdowns of mortality attributed to individual diseases by sex. It could potentially be helpful to researchers of specific diseases to also have estimates of a disease\'s contribution to mortality associated with population ageing independent of sex. While this could be difficult given differences in sex ratios across countries and, as the authors point out, with ageing, I wonder if the authors could use their decomposition approach to provide this.

3\. In the section \"Population Ageing\", it could be helpful if the authors report the magnitude of ageing according to the income groupings (high, upper middle, lower middle, and low) that the authors use elsewhere in the results section.

4\. The authors report negative values in low income countries for the proportion of death increases attributable to population ageing. They explain: \"The negative percentages in low-income countries reflect decreases in the proportion of old age groups\" (p. 10). I found this slightly confusing - does this suggest that low-income countries\' populations were negatively ageing (getting younger)? This point could be clarified in more detail.

5\. Given the novelty of their statistical method, I wonder if sensitivity analyses could provide converging evidence for their findings (e.g., giving very brief examples of countries that differ in age but with similar incomes and reporting the differences in mortality etc.).

6\. In the discussion, the authors discuss the tension between population ageing and mortality reduction from specific disease through prevention strategies and improved healthcare. This seems somewhat of a paradox to me - if mortality from a disease is reduced, I would have thought that would lead to further ageing, which, in turn, could eventually lead to mortality from other causes. Perhaps I am missing something, but maybe the authors could clarify this point and discuss this issue.

The validity of the findings rests on a statistical approach that the authors themselves developed and published recently (Cheng et al., 2019, PLoS One). I do not have expertise in these statistics to evaluate this part of the paper. I would suggest that the editors obtain a review from a statistician in the area if they have not already.

Any attachments provided with reviews can be seen via the following link:

\[LINK\]

10.1371/journal.pmed.1003138.r002
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20 Apr 2020

Dear Dr. Hu,

Thank you very much for re-submitting your manuscript \"Population ageing and mortality during 1990-2017: a global decomposition analysis\" (PMEDICINE-D-19-03747R1) for review by PLOS Medicine.

I have discussed the paper with my colleagues and the academic editor and it was also seen again by three reviewers. I am pleased to say that provided the remaining editorial and production issues are dealt with we are planning to accept the paper for publication in the journal.

The remaining issues that need to be addressed are listed at the end of this email. Any accompanying reviewer attachments can be seen via the link below. Please take these into account before resubmitting your manuscript:

\[LINK\]

Our publications team (<plosmedicine@plos.org>) will be in touch shortly about the production requirements for your paper, and the link and deadline for resubmission. DO NOT RESUBMIT BEFORE YOU\'VE RECEIVED THE PRODUCTION REQUIREMENTS.

\*\*\*Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.\*\*\*

In revising the manuscript for further consideration here, please ensure you address the specific points made by each reviewer and the editors. In your rebuttal letter you should indicate your response to the reviewers\' and editors\' comments and the changes you have made in the manuscript. Please submit a clean version of the paper as the main article file. A version with changes marked must also be uploaded as a marked up manuscript file.

Please also check the guidelines for revised papers at <http://journals.plos.org/plosmedicine/s/revising-your-manuscript> for any that apply to your paper. If you haven\'t already, we ask that you provide a short, non-technical Author Summary of your research to make findings accessible to a wide audience that includes both scientists and non-scientists. The Author Summary should immediately follow the Abstract in your revised manuscript. This text is subject to editorial change and should be distinct from the scientific abstract.

We expect to receive your revised manuscript within 1 week. Please email us (<plosmedicine@plos.org>) if you have any questions or concerns.

We ask every co-author listed on the manuscript to fill in a contributing author statement. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT.

Please ensure that the paper adheres to the PLOS Data Availability Policy (see <http://journals.plos.org/plosmedicine/s/data-availability>), which requires that all data underlying the study\'s findings be provided in a repository or as Supporting Information. For data residing with a third party, authors are required to provide instructions with contact information for obtaining the data. PLOS journals do not allow statements supported by \"data not shown\" or \"unpublished results.\" For such statements, authors must provide supporting data or cite public sources that include it.

If you have any questions in the meantime, please contact me or the journal staff on <plosmedicine@plos.org>.

We look forward to receiving the revised manuscript by Apr 27 2020 11:59PM.

Sincerely,

Thomas McBride, PhD

Senior Editor

PLOS Medicine

[plosmedicine.org](http://plosmedicine.org)
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Requests from Editors:

1- Abstract Background: "older people" or "older adults" rather than "old people".

2- Abstract Methods and Findings and going forward, please consider using "high- and middle-income countries" and "low-income countries" rather than "countries with middle to high income levels", unless these categories in your study do not line up with the WHO categories. If the latter is true, please make the distinction clear.

3- Abstract Methods and Findings, line 37: perhaps clearer to say "Compared to 1990, 12 million additional global deaths in 2017 were attributed to population ageing, corresponding to 27.9% of total global deaths." (If my rewording is accurate).

4- Line 48: rather than "about 50%", please state the absolute numbers for the numerator and denominator.

5- Starting in the Abstract and throughout the manuscript, please avoid causal language (e.g., "Population ageing caused increases in the number of deaths in countries with middle to high income levels but not for countries with low income") and use "attributable for" or similar.

6- Thank you for adding an Author Summary. Point number 7 ("The reduction in number of deaths from 1990 to 2017 from mortality change exceeds the increase of deaths caused by population ageing for the whole world and in about 50% of countries where population ageing was associated with increased death burden.") is a bit confusing. It would be appropriate to split into two sentences to clarify.

7- Please qualify the first sentence of the last paragraph of the Introduction with "to our knowledge" or similar.

8- Line 167: please delete "robust".

9- Line 189: please delete "new".

10- Results section: thank you for including the absolute numbers that correspond to percentages in the tables. Please also include absolute numbers when citing the percentages in the text.

11- Line 386: if you describe the decomposition method as "robust", please explain here what makes it robust.

12- Again on lines 400, 407, and 426, please either describe how this method is robust or delete "robust".

Comments from Reviewers:

Reviewer \#1: The authors have addressed my concerns and I now recommend publication

Peter Flom

Reviewer \#2: The authors have taken the comments seriously which resulted in a more cautious interpretation of their efforts.

Reviewer \#4: The authors have addressed my comments.

Any attachments provided with reviews can be seen via the following link:

\[LINK\]

10.1371/journal.pmed.1003138.r004
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13 May 2020

Dear Dr. Hu,

On behalf of my colleagues and the academic editor, Dr. Sanjay Basu, I am delighted to inform you that your manuscript entitled \"Population ageing and mortality during 1990-2017: a global decomposition analysis\" (PMEDICINE-D-19-03747R2) has been accepted for publication in PLOS Medicine.

PRODUCTION PROCESS

Before publication you will see the copyedited word document (in around 1-2 weeks from now) and a PDF galley proof shortly after that. The copyeditor will be in touch shortly before sending you the copyedited Word document. We will make some revisions at the copyediting stage to conform to our general style, and for clarification. When you receive this version you should check and revise it very carefully, including figures, tables, references, and supporting information, because corrections at the next stage (proofs) will be strictly limited to (1) errors in author names or affiliations, (2) errors of scientific fact that would cause misunderstandings to readers, and (3) printer\'s (introduced) errors.

If you are likely to be away when either this document or the proof is sent, please ensure we have contact information of a second person, as we will need you to respond quickly at each point.

PRESS

A selection of our articles each week are press released by the journal. You will be contacted nearer the time if we are press releasing your article in order to approve the content and check the contact information for journalists is correct. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact.

PROFILE INFORMATION

Now that your manuscript has been accepted, please log into EM and update your profile. Go to <https://www.editorialmanager.com/pmedicine>, log in, and click on the \"Update My Information\" link at the top of the page. Please update your user information to ensure an efficient production and billing process.

Thank you again for submitting the manuscript to PLOS Medicine. We look forward to publishing it.

Best wishes,

Thomas McBride, PhD

Senior Editor

PLOS Medicine

[plosmedicine.org](http://plosmedicine.org)
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